Accelerate Diagnostics, Inc. (NASDAQ:AXDX) director Jack Schuler, Buys $200000 in Stock

May 18, 2018 - By Robert Crowder

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Logo

Jack Schuler Insider Buy

The director of Accelerate Diagnostics Inc and corporation’s insider Jack Schuler purchased 10,000 shares of the stock exchange listed company based on the average $20.0 a share . Jack Schuler’s shares have a value of approximately $200,000 US Dollars. This is not his first insider trade, in the last month, he bought another 165,000 shares worth $3.23 million USD. The transaction was huge and not likely to remain disregarded. Jack Schuler right now holds 10%+ of the Company’s total market capitalization with ownership of 689,355 shares. 

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.82, from 1.63 in 2017Q3. It dropped, as 21 investors sold Accelerate Diagnostics, Inc. shares while 32 reduced holdings. 15 funds opened positions while 28 raised stakes. 19.90 million shares or 6.66% less from 21.32 million shares in 2017Q3 were reported.

Kornitzer Mngmt Inc Ks has 0.2% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). 8,727 were reported by Metropolitan Life Ins Ny. Raymond James & reported 0% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Rhumbline Advisers stated it has 26,086 shares or 0% of all its holdings. Bokf Na accumulated 10,384 shares. Aqr Cap Limited Liability invested in 0% or 7,739 shares. Cannell Peter B And has invested 1.01% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Manufacturers Life Communication The invested 0% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Nuveen Asset Mngmt Ltd Company has invested 0.11% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Gilder Gagnon Howe Limited Liability accumulated 61,420 shares or 0.02% of the stock. Northern Trust Corporation invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Blair William & Il accumulated 1.02 million shares. National Bank Of Mellon Corp reported 128,395 shares or 0% of all its holdings. Cypress Mgmt Limited Liability Corporation (Wy) holds 211 shares or 0.01% of its portfolio.

Since February 20, 2018, it had 7 insider buys, and 0 selling transactions for $4.73 million activity.

The stock increased 2.31% or $0.5 during the last trading session, reaching $22.15. About 362,468 shares traded or 55.53% up from the average. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 0.88% since May 18, 2017 and is downtrending. It has underperformed by 12.43% the S&P500.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. The company has market cap of $1.20 billion. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. It currently has negative earnings. The firm was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012.

Analysts await Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to report earnings on August, 2. They expect $-0.37 EPS, down 19.35 % or $0.06 from last year’s $-0.31 per share. After $-0.37 actual EPS reported by Accelerate Diagnostics, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

More recent Accelerate Diagnostics, Inc. (NASDAQ:AXDX) news were published by: which released: “Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th” on April 30, 2018. Also published the news titled: “Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018” on April 21, 2018.‘s news article titled: “Report: Developing Opportunities within US Ecology, Universal Health Realty Income Trust, Accelerate Diagnostics ..” with publication date: May 04, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: